CA
TEVA icon

Continuum Advisory’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Continuum Advisory’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.6K Buy
+491
New +$16.4K ﹤0.01% 1097
2025
Q2 		– Sell
-1,339
Closed -$20.6K – 1448
2025
Q1 		$20.6K Buy
1,339
+58
+5% +$1.04K ﹤0.01% 853
2024
Q4 		$28.2K Buy
1,281
+106
+9% +$1.93K ﹤0.01% 775
2024
Q3 		$19.7K Buy
1,175
+847
+258% +$14.8K ﹤0.01% 850
2024
Q2 		$5.33K Buy
328
+83
+34% +$1.28K ﹤0.01% 1069
2024
Q1 		$3.92K Buy
+245
New +$3.09K ﹤0.01% 1118

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Continuum Advisory's TEVA Position: Q2 2026 in Review

Continuum Advisory opened a new position in Teva Pharmaceutical Industries Limited (TEVA) in Q2 2026: 491 shares worth $16.6K. The stake represents ﹤0.01% of the portfolio and ranks #1097 among its holdings. This is a return to the name: Continuum Advisory previously reported a position in TEVA as recently as Q1 2025.

Continuum Advisory first reported a position in TEVA in Q1 2024 and has held it in 6 quarters since. The position peaked at $28.2K in Q4 2024. 676 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Continuum Advisory held 491 shares of Teva Pharmaceutical Industries Limited worth $16.6K as of Q2 2026.
  • Teva Pharmaceutical Industries Limited was a new Continuum Advisory position in Q2 2026.
  • Teva Pharmaceutical Industries Limited made up ﹤0.01% of Continuum Advisory's portfolio in Q2 2026, its #1097 holding.
  • Continuum Advisory first reported a position in Teva Pharmaceutical Industries Limited in Q1 2024 and has held it in 6 quarters since.
  • Continuum Advisory's Teva Pharmaceutical Industries Limited position peaked at $28.2K in Q4 2024.
  • 676 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q2 2026.

Based on Continuum Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.